Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

18 Dec 2025 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Travoprost Ophthalmic Solution USP, 0.004% (Ionic Buffered Solution). Enclosed press release of the same.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1807.00
Dr. Reddys Labs. 1355.00
Cipla 1374.20
Lupin 2009.10
Zydus Lifesciences 1234.00
View more..